XYREM — 1304721
Application number
1304721
Registration number
TMA759794
Type(s)
Word
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2006-06-08
Registered
2010-02-18
Registration Expiry Date
2035-02-18
Current owner
Jazz Pharmaceuticals, Inc.
3000 El Camino Real
2 Palo Alto Square, Suite 600
Palo Alto, CA 94306
UNITED STATES OF AMERICA
Agent
GOWLING WLG (CANADA) LLP
SUITE 1600
1 FIRST CANADIAN PLACE
100 KING STREET WEST
TORONTO
ONTARIO M5X1G5
Registered Owner
JPI Commercial, LLC
a Delaware limited liability company
3180 Porter Drive
Palo Alto, California, 94304
UNITED STATES OF AMERICA
Applicant
Orphan Medical, Inc.
3180 Porter Drive
Palo Alto, California 94304
UNITED STATES OF AMERICA
Old Owner
Orphan Medical, Inc.
3180 Porter Drive
Palo Alto, California 94304
UNITED STATES OF AMERICA
Old Owner
ORPHAN MEDICAL, LLC
A Delaware Limited Liability Company
3180 Porter Drive
Palo Alto, California 94304
UNITED STATES OF AMERICA
Documents
Index headings
- XYREM
Goods (Nice class & Statement)
- 5
- (1) Pain relief medication; preparation for the relief of pain; pharmaceutical preparations for the treatment of disorders affecting the central nervous system, namely drug and alcohol addiction, conduct disorder, oppositional defiant disorder, attention deficit disorders, amnestic disorders, autism, schizophrenia, psychosis, depression, chronic fatigue syndrome, anxiety, irritable bowel disorder, narcolepsy, fibromyalgia, insomnia, and myositis; pharmaceutical preparations for use in the treatment and management of sleep disorders, chronic fatigue syndrome, drug and alcohol abuse, anxiety, cerebrovascular diseases, neurological disorders, namely essential tremor, tic disorders, Tourette's syndrome, Parkinson's disease, Huntington's disease, restless leg syndrome, myoclonus, dystonias, dementia, Alzheimer's disease, learning disabilities, multiple sclerosis, sleep disorders, post surgical pain, post-trauma pain, neuropathic pain and diabetic pain, autism, depression, inflammatory disorders, namely inflammatory bowel disorder, regional ileitis, ulcerative colitis, irritable bowel disorder, autoimmune inflammatory disorders, endocrine disturbances, and diabetes; and pharmaceutical preparations for the purpose of tissue protection namely, tissue protection following hypoxia/anoxia as in the case of stroke, organ transplantation, organ preservation, myocardial infarction or ischemia, reperfusion injury, and protection following radiation, progeria, or an increased level of intracranial pressure as in the case of head trauma.
- 5
- (2) Pain relief medication; preparation for the relief of pain; pharmaceutical preparations for the treatment of disorders affecting the central nervous system, namely drug and alcohol addiction, depression, chronic fatigue syndrome, anxiety, narcolepsy, fibromyalgia, insomnia; pharmaceutical preparations for use in the treatment and management of sleep disorders, chronic fatigue syndrome, drug and alcohol abuse, neurological disorders, namely essential tremor, tic disorders, Tourette's syndrome, Parkinson's disease, Huntington's disease, restless leg syndrome, myoclonus, dystonias, Alzheimer's disease, sleep disorders, post surgical pain, post-trauma pain or neuropathic pain and diabetic pain.
Claims
- Priority Filing Date: December 08, 2005, Country or Office: UNITED STATES OF AMERICA, Application No. 78/769,796 in association with the same kind of goods (1)
- Used in UNITED STATES OF AMERICA on goods (1)
- Registered in or for UNITED STATES OF AMERICA on October 09, 2007, under No. 3,309,255 on goods (1)
- Declaration of Use filed August 06, 2009 on goods (2)
Recordals (known also as Footnotes)
CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Assignment / Cession DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2016-04-12 DATE OF CHANGE / DATE DE CHANGEMENT: 2016-02-25 COMMENTS / COMMENTAIRES: FROM: JPI Commercial, LLC a Delaware limited liability company TO: Jazz Pharmaceuticals, Inc. Voir Preuve au dossier/See evidence on File No. 1304721 Owner Address Change / Changement d'adresse du propriétaire DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2025-10-29Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2006-06-08 | ||
| Created | 2006-06-09 | ||
| Formalized | 2006-06-09 | ||
| Search Recorded | 2006-10-31 | ||
| Examiner's First Report | 2006-10-31 | 2007-02-28 | |
| Correspondence Created | 2007-03-07 | 2007-08-28 | |
| Extension of Time | 2007-09-12 | 2008-02-28 | Request Letter Date: 2007/08/28 |
| Approved | 2008-09-05 | ||
| Note to file | 2008-09-12 | Correction to wares as per request dated September 09, 2008. | |
| Advertised | 2008-10-22 | Vol.55 Issue 2817 | |
| Allowed | 2009-02-06 | ||
| Allowance Notice Sent | 2009-02-06 | 2009-08-06 | |
| Amendment to Application | 2009-11-25 | Merger / Voir Preuve au dossier/See evidence on File No. 1023221 | |
| Change of Title Registered | 2009-11-25 | Assignment / Voir Preuve au dossier/See evidence on File No. 1023221 | |
| Registered | 2010-02-18 | 2025-02-18 | |
| Change of Title Registered | 2016-04-12 | Assignment / Voir Preuve au dossier/See evidence on File No. 1304721 | |
| Agent Changed | 2019-08-16 | From: 10425 To: 32 / Voir Preuve au dossier/See evidence on File No. 1355599 | |
| Renewed | 2025-02-18 | 2035-02-18 | DP:2024/12/30 RD:2024/12/30 RR:(8390) GOWLING WLG (CANADA) LLP |
| Nice Class(es) Acceptance Letter Sent | 2025-03-25 | ||
| Amendment to Registration | 2025-10-29 | Address/address |